Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 170 | 170 | 186 | 156 | 144 |
| Income taxes - deferred | -18 | -23 | 55 | -49 | -33 |
| Accounts receivable | -56 | 3 | -207 | 130 | 1 |
| Other Working Capital | -37 | -170 | -228 | 981 | -1,276 |
| Other Operating Activity | -814 | -922 | -868 | -1,224 | -1,086 |
| Operating Cash Flow | $-754 | $-941 | $-1,061 | $-6 | $-2,250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -294 | -74 | 1 | -102 | -19 |
| Net Acquisitions | 0 | 0 | 0 | -735 | -273 |
| Sale Of Investment | 0 | 0 | 82 | 0 | 33 |
| Other Investing Activity | 0 | 0 | -200 | 0 | 0 |
| Investing Cash Flow | $-294 | $-74 | $-117 | $-836 | $-260 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -55 | -55 | -65 | -39 | -33 |
| Other Financing Activity | -15 | 102 | 50 | 0 | 0 |
| Financing Cash Flow | $-71 | $47 | $-15 | $-39 | $-33 |
| Exchange Rate Effect | -13 | -22 | -16 | 103 | -2 |
| Beginning Cash Position | 17,495 | 18,487 | 19,696 | 20,475 | 23,019 |
| End Cash Position | 16,364 | 17,495 | 18,487 | 19,696 | 20,475 |
| Net Cash Flow | $-1,119 | $-969 | $-1,193 | $-882 | $-2,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -754 | -941 | -1,061 | -6 | -2,250 |
| Capital Expenditure | -294 | -94 | N/A | -102 | -19 |
| Free Cash Flow | -1,048 | -1,036 | -1,061 | -108 | -2,269 |